Clonidine as a First-Line Sedative Agent After Neonatal Cardiac Surgery: Retrospective Cohort Study.

Area of Science:

• Pediatric Cardiology
• Critical Care Medicine
• Pharmacology

Background:

• Sedation is crucial for infants post-cardiac surgery.
• Clonidine's cardiovascular effects in this population require evaluation.
• Limited data exists on clonidine as a first-line sedative in neonates after cardiac procedures.

Purpose of the Study:

• To assess the cardiovascular tolerance of intravenous clonidine.
• To evaluate clonidine as a first-line sedative in infants under two months old following cardiac surgery.
• To compare clonidine's hemodynamic effects with midazolam.

Main Methods:

• Retrospective chart review of infants younger than 2 months.
• Analysis of cardiovascular parameters including heart rate, blood pressure, and pressures.
• Comparison of pre- and post-clonidine infusion data.

Main Results:

• Clonidine infusion resulted in a statistically significant decrease in heart rate (12%) and a transient drop in diastolic blood pressure (13%).
• Other hemodynamic variables, including central venous pressure, left atrial pressure, and vasoactive inotropic score, remained stable or improved.
• Only 23 of 224 eligible infants met inclusion criteria, with most receiving alternative sedation.

Conclusions:

• Intravenous clonidine appears hemodynamically safe when used as an adjunctive sedative to morphine in select infants post-cardiac surgery.
• The observed decreases in heart rate and diastolic blood pressure were clinically insignificant.
• Further research is warranted to explore the safety and efficacy of early clonidine administration as an alternative to midazolam in pediatric cardiac intensive care.